Alice Chu
Clifton, NJNPI 1962513366
Payments from drug & device makers
What this record shows
This record is dominated by other: $164,112 of the $167,239 with a category attached, or 98.1%. Johnson & Johnson accounts for 98.3% of it on its own, with 16 other manufacturers making up the rest. 2021 is the largest year on record at $164,112, more than ten times the $3,034 reported in 2019.
Across 200 payments — averaging $836.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$164K
- Amgen$897
- Sanofi$547
- AbbVie$278
- Novartis$165
- Pfizer$161
- plus $824 from 11 others
What the payments were for
- Travel & lodging$4120%
- Food & beverage$2,6142%
- Education$1000%
- Other$164,11298%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(3 entities) | 20 | $164,366 |
| Amgen(2 entities) | 27 | $897 |
| Sanofi | 33 | $547 |
| AbbVie | 16 | $278 |
| Novartis | 22 | $165 |
| Pfizer | 18 | $161 |
| Sanofi-aventis U.S. LLC | 3 | $129 |
| Mallinckrodt Enterprises LLC | 11 | $119 |
| E.r. Squibb & Sons, L.L.C. | 13 | $118 |
| GSK | 12 | $114 |
| Lilly USA, LLC | 7 | $102 |
| UCB, Inc. | 5 | $62 |
| Ferring Pharmaceuticals Inc. | 4 | $60 |
| Radius Health, Inc. | 3 | $43 |
| Genentech USA, Inc. | 3 | $39 |
| Medexus Pharma, Inc. | 2 | $25 |
| Sobi, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.